共 7 条
[1]
Beyond immunosuppression-challen-ges in the clinical management of lupus nephritis. Masood S,Jayne D,Karim Y. Lupus . 2009
[2]
Induction treatment of pro-liferative lupus nephritis with leflunomide combined with predni-sone:a prospective multicentre observational study. Wang H Y,,Gui T G,Hou F F,et al. Lupus . 2008
[3]
Update on immunotherapy for systemic lupus erythematosus—what s hot and what s not!. Karim MY,Pisoni CN,Khamashta MA. Rheumatology . 2009
[4]
The10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose ver-sus high-dose intravenous cyclophosphamide. Houssiau FA,Vasconcelos C,D Cruz D,et al. Annals of the Rheumatic Diseases . 2009
[5]
Pharmacokinetics of mycophenolic acid in patients with lupus nephritis. Joy MS,Hilliard T,Hu Y,et al. Pharmacotherapy . 2009
[6]
Rituximab and mycophe-nolate mofetil for relapsing proliferative lupus nephritis:a long-term prospective study. Boletis JN,Marinaki S,Skalioti C,et al. Nephrology Dialysis Transplantation . 2009
[7]
Successful treatment of classⅤ+Ⅳlupus nephritis with multitarget therapy. Bao H,Liu ZH,Xie HL,et al. Journal of the American Society of Nephrology . 2008